Vestor Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Vestor Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72K	Buy	+422	New	+$57K	﹤0.01%	228
2019 Q4	–	Sell	-695	Closed	-$53K	–	171
2019 Q3	$53K	Hold	695	–	–	0.01%	123
2019 Q2	$61K	Sell	695 -98	-12%	-$8.36K	0.01%	104
2019 Q1	$72K	Sell	793 -1,475	-65%	-$125K	0.01%	112
2018 Q4	$163K	Sell	2,268 -37,396	-94%	-$3.01M	0.04%	72
2018 Q3	$3.8M	Sell	39,664 -550	-1%	-$53.3K	0.74%	46
2018 Q2	$3.83M	Sell	40,214 -195	-0.5%	-$17.9K	0.78%	45
2018 Q1	$3.54M	Buy	40,409 +1,143	+3%	+$104K	0.73%	44
2017 Q4	$3.33M	Buy	39,266 +145	+0.4%	+$12.1K	0.72%	48
2017 Q3	$3.39M	Buy	39,121 +458	+1%	+$36.7K	0.76%	47
2017 Q2	$2.98M	Buy	38,663 +208	+0.5%	+$14.8K	0.73%	49
2017 Q1	$2.67M	Buy	+38,455	New	+$2.58M	0.58%	63

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Vestor Capital's XBI Position: Q2 2026 in Review

Vestor Capital opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 422 shares worth $72K. The stake represents ﹤0.01% of the portfolio and ranks #228 among its holdings. This is a return to the name: Vestor Capital previously reported a position in XBI as recently as Q3 2019.

Vestor Capital first reported a position in XBI in Q1 2017 and has held it in 12 quarters since. The position peaked at $3.83M in Q2 2018. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Vestor Capital held 422 shares of State Street SPDR S&P Biotech ETF worth $72K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Vestor Capital position in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Vestor Capital's portfolio in Q2 2026, its #228 holding.
Vestor Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 12 quarters since.
Vestor Capital's State Street SPDR S&P Biotech ETF position peaked at $3.83M in Q2 2018.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Vestor Capital's 13F filing for Q2 2026, filed 28 Jul 2026.